Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Roche and Labcyte Integrate Echo and LightCycler Systems to Increase Performance of qPCR-based RNA/DNA Analyses

Published: Wednesday, December 07, 2011
Last Updated: Wednesday, December 07, 2011
Bookmark and Share
Companies cooperate around high-speed, miniaturized quantitative PCR (qPCR) to monitor the expression of tens to thousands of genes for therapeutic research.

The RealTime ready Cell Lysis kit from Roche enables gene expression directly from cell lysates. Coupled with Echo(R) liquid handlers and newly-released tissue culture microplates from Labcyte, researchers can greatly simplify high-throughput qPCR analyses. This process can be fully automated using the Access(TM) Workstation from Labcyte which integrates the Echo liquid handler with either the LightCycler 480 or LightCycler 1536 Instrument. Gene expression profiles derived in a one-step process directly from cells can now be streamlined into a simple automated workflow, significantly increasing productivity.

"The LightCycler 480 and 1536 Systems are designed for high-throughput gene detection, gene expression, and genetic variation analysis. Unlike other high throughput systems on the market that offer greater than 384 well capability, the Lightcycler 1536 allows for individual well to well addressability and optimization due to its true qPCR nature," said Dr. Matthias Hinzpeter, Project Leader qPCR/NAP Systems. "This integrated platform reduces data costs associated with gene expression profiling, allowing efficient incorporation of qPCR into the early stages of drug discovery."

"The Echo liquid handlers use acoustic energy to transfer precise nanoliter volumes of samples, primers, probes and real-time PCR reagents," said Stephen Bates, Labcyte Senior Vice President. "Our patented acoustic dispensing eliminates the need for pipette tips and completely removes the risk of cross contamination. The simplicity of plate reformatting and cherry picking features in our Echo software applications suite maximizes PCR layout flexibility without fixed format constraints."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Roche and Agilent to Provide Continued Service and Support to Roche NimbleGen Microarray Customers
Transition of services beginning immediately.
Wednesday, November 07, 2012
Hamilton Introduces Automated DNA Sample Enrichment Solution
System uses Roche 454 REM e liquid handling system to replace hours of manual work.
Tuesday, January 31, 2012
Canterbury Health Laboratories (NZ) Adopts NimbleGen Microarray Cytogenetics Solution for Mental Retardation Research
Roche NimbleGen have announced that one of New Zealand’s largest medical laboratories has adopted the NimbleGen CGX Cytogenetics Microarray Solution.
Monday, November 15, 2010
DNA Electronics Partners with Roche to Develop Semiconductor Based Sequencing System
Collaboration to focus on development of a low-cost, high-throughput, long read, high density DNA sequencing system.
Tuesday, November 02, 2010
Gene Biodesign Certified to Provide NimbleGen Array Services in Taiwan
Gene Biodesign has been certified to process customer samples in northern Taipei county for NimbleGen array applications.
Friday, October 15, 2010
Macrogen, Inc. Certified as NimbleGen Array Service Provider for Korea
Macrogen has been certified to process customer samples for NimbleGen CGH/CNV services in their lab in Seoul.
Wednesday, July 14, 2010
Roche NimbleGen Commits to GMP and FDA Submission for Microarrays
Roche NimbleGen announces a company-wide initiative to implement Good Manufacturing Processes for its suite of DNA microarrays.
Thursday, April 08, 2010
Roche Collaborates with Merck on Developmental Test for Cancer-Related Gene Mutation
Investigational AmpliChip p53 test designed to screen for genetic mutation tied to therapeutic resistance in cancer patients.
Friday, February 19, 2010
CapitalBio Corporation Certified to Provide NimbleGen Array Services in China
CapitalBio becomes the first NimbleGen CSP in Asia to implement the MS 200 Microarray Scanner.
Monday, February 15, 2010
imaGenes GmbH Joins Roche NimbleGen’s Certified Service Provider Program for ChIP-chip Analysis
imaGenes achieves status as a CSP of NimbleGen microarrays for Chromatin Immunoprecipitation.
Wednesday, December 16, 2009
Roche and High Throughput Genomics Partner for Advanced Gene Expression Analysis Solution
Roche NimbleGen will provide HTG with high density, multiplex DNA microarray slides for advanced gene expression analysis.
Monday, November 09, 2009
Roche Applied Science Announces CGX Arrays Designed by Signature Genomics for Microarray-based Cytogenetic Analysis
The CGX arrays are designed by Signature Genomic Laboratories to provide high-resolution, genome-wide analysis of chromosomal abnormalities.
Monday, November 09, 2009
Roche and High Throughput Genomics Partner for Advanced Gene Expression Analysis Solution
Roche NimbleGen and High Throughput Genomics, Inc. (HTG), provider of the quantitative Nuclease Protection Assay (qNPA), have entered into a supply agreement. Under the agreement, Roche NimbleGen will provide HTG with high density, multiplex DNA microarray slides for advanced gene expression analysis.
Wednesday, October 21, 2009
Roche NimbleGen CGH Microarrays Enable the First Maps of Genome-Wide DNA CNV in Dogs
Studies reveal that the extent of CNVs in the dog genome and their association with known and candidate disease genes is similar to mice and humans.
Friday, May 08, 2009
Roche NimbleGen Microarrays Selected for the Neuromuscular Disorder -Chip Consortium
The NMD-Chip Consortium selects Roche NimbleGen microarrays to accelerate and simplify genetic research of neuromuscular disorders.
Friday, February 27, 2009
Scientific News
Paving the way to Better Ovarian Cancer Diagnosis
Aïcha BenTaieb will present her invention for automated identification of ovarian cancer’s many subtypes at an international conference this fall.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Futuristic Brain Probe Allows for Wireless Control of Neurons
NIH-funded scientists developed an ultra-thin, minimally invasive device for controlling brain cells with drugs and light.
Microfluidic Device Mixes And Matches DNA For Synthetic Biology
Researchers have developed a microfluidic device that quickly builds packages of DNA and delivers them into bacteria or yeast for further testing.
Artificial Pancreas Controls Diabetes
Scientists are reporting the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar, or glucose, level and can automatically release insulin as needed.
Major Step for Implantable Drug-Delivery Device
MIT spinout signs deal to commercialize microchips that release therapeutics inside the body.
Smart Insulin Patch Could Replace Painful Injections for Diabetes
A joint effort between diabetes doctors and biomedical engineers could revolutionize how people with diabetes keep their blood sugar levels in check.
The Secrets of Secretion
Researchers have hacked nature's blueprints to create a new technology that could have broad-reaching impact on drug delivery systems and self-healing and anti-fouling materials.
New Tool on Horizon for Surgeons Treating Cancer Patients
Surgeons could know while their patients are still on the operating table if a tissue is cancerous, according to researchers.
Heartbeat on a Chip Could Improve Pharmaceutical Tests
A gravity-powered chip that can mimic a human heartbeat outside the body could advance pharmaceutical testing and open new possibilities in cell culture because it can mimic fundamental physical rhythms.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!